Delta Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Delta Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.4K	Hold	16,000	–	–	﹤0.01%	290
2026 Q1	$49.1K	Hold	16,000	–	–	﹤0.01%	274
2025 Q4	$57K	Buy	16,000 +3,000	+23%	+$18.4K	﹤0.01%	251
2025 Q3	$116K	Buy	13,000 +1,000	+8%	+$10.1K	0.01%	191
2025 Q2	$111K	Buy	12,000 +1,000	+9%	+$8.54K	0.01%	188
2025 Q1	$94.4K	Buy	11,000 +9,000	+450%	+$85K	0.01%	195
2024 Q4	$21.5K	Buy	+2,000	New	+$15.4K	﹤0.01%	360

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Delta Asset Management's AVXL Position: Q2 2026 in Review

Delta Asset Management held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 16,000 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #290.

Delta Asset Management first reported a position in AVXL in Q4 2024 and has held it in 7 quarters since. The position peaked at $116K in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

Delta Asset Management held 16,000 shares of Anavex Life Sciences worth $41.4K as of Q2 2026.
Delta Asset Management left its Anavex Life Sciences share count unchanged in Q2 2026.
Anavex Life Sciences made up ﹤0.01% of Delta Asset Management's portfolio in Q2 2026, its #290 holding.
Delta Asset Management first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 7 quarters since.
Delta Asset Management's Anavex Life Sciences position peaked at $116K in Q3 2025.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Delta Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.